CVS Pharmacy® (NYSE: CVS) has announced that the updated COVID-19 vaccines for the 2024-2025 season, along with flu vaccines, are now available at CVS Pharmacy and MinuteClinic® locations nationwide. Walk-ins…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved PiaSky® (crovalimab), a novel monoclonal antibody designed to inhibit the complement protein C5, for the treatment…
Hinge Health and Midi Health have announced a partnership aimed at addressing the significant healthcare gap for women undergoing menopause. This collaboration merges Hinge Health’s expertise in movement-based support for…
MedImpact Healthcare Systems, Inc., the largest independent provider of health solutions, technology, and pharmacy benefit services in the U.S., announced today the expansion of access to Humira biosimilars—Simlandi and adalimumab-adaz—for…
Avanzanite Bioscience BV, a specialty pharmaceutical company in the development stage, has announced that the European Commission (EC) has granted marketing authorization for AKANTIOR® (polihexanide), a treatment for acanthamoeba keratitis…
OMNY Health, a leader in creating compliant cross-industry data partnerships, has announced the launch of its Glucagon-Like Peptide-1 (GLP-1) data network, reinforcing its mission to democratize healthcare data. This new…
Quantum-Si Incorporated (Nasdaq: QSI), known as “The Protein Sequencing Company™,” has announced key leadership appointments. Effective September 17, 2024, Todd Bennett will join the company as the new Chief Commercial…
The new report, “Pharmaceutical Processing and Packaging Equipment Market: Size, Share, Forecast, and Trends Analysis by Formulation, Secondary Packaging, and End-of-Line Packaging – Global Forecast to 2031,” is now available…
Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), a leader in interventional oncology specializing in the treatment of primary and metastatic liver cancers, has announced the publication of an…
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the European Commission (EC) has granted approval for Ordspono™ (odronextamab) to treat adult patients with relapsed or refractory (R/R) follicular lymphoma (FL)…
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that 20 abstracts related to Dupixent® (dupilumab) and the investigational therapy itepekimab will be presented at the European Respiratory Society (ERS) Congress 2024,…
Bristol Myers Squibb (NYSE: BMY) has announced that it will present research findings from its comprehensive cardiovascular portfolio at the European Society of Cardiology (ESC) Congress, scheduled for August 30…